Pyrazoler, farmasøytisk preparat inneholdende samme, slike forbindelser som terapeutisk aktive substanser samt slike forbindelser for anvendelse i behandling av sykdommer
Det er her tilveiebrakt forbindelser med formel (I): så vel som farmasøytisk akseptable salter derav, hvor substituentene er som beskrevet i beskrivelsen. Disse forbindelsene og de farmasøytiske preparatene som inneholder dem, er anvendelige for behandling av sykdommer som for eksempel diabetes mell...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | nor |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | Anderson, Kevin William Fotouhi, Nader Pietranico-Cole, Sherrie Lynn Qi, Lida Goodnow Jr, Robert Alan Scott, Nathan Robert Guertin, Kevin Richard Tilley, Jefferson Wright Myers, Michael Paul Rossman, Pamela Loreen Zhang, Qiang Gillespie, Paul Haynes, Nancy-Ellen Thakkar, Kshitij Chhabilbhai |
| description | Det er her tilveiebrakt forbindelser med formel (I): så vel som farmasøytisk akseptable salter derav, hvor substituentene er som beskrevet i beskrivelsen. Disse forbindelsene og de farmasøytiske preparatene som inneholder dem, er anvendelige for behandling av sykdommer som for eksempel diabetes mellitus type II og metabolsk syndrom.
Provided herein are compounds of the formula (I):
as well as pharmaceutically acceptable salts thereof, wherein the substituents are as those disclosed in the specification. These compounds, and the pharmaceutical compositions containing them, are useful for the treatment of diseases such as, for example, type II diabetes mellitus and metabolic syndrome. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_NO341746BB1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>NO341746BB1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_NO341746BB13</originalsourceid><addsrcrecordid>eNqNjT0KwkAQhdNYiHqHOUAsgqK9oliphb1MzMQs-8vMJhCv5AXsvZiLWlpYPd7j-3jD7H7sGW_eEOdQI1uU56OPSjQEpoCMEZRz1HhTkasIBK2lHMQoTVB7LlVajRCDeAuRGAO1bx91VF0S2lIiujeBNv4yUwF0HX06KCipQVcZ5a6AHUivK59eeZwNakzE5JujDLab03o3peDPJAEv5Cie94fZvFjOF6tVMfsDeQGfVFuu</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Pyrazoler, farmasøytisk preparat inneholdende samme, slike forbindelser som terapeutisk aktive substanser samt slike forbindelser for anvendelse i behandling av sykdommer</title><source>esp@cenet</source><creator>Anderson, Kevin William ; Fotouhi, Nader ; Pietranico-Cole, Sherrie Lynn ; Qi, Lida ; Goodnow Jr, Robert Alan ; Scott, Nathan Robert ; Guertin, Kevin Richard ; Tilley, Jefferson Wright ; Myers, Michael Paul ; Rossman, Pamela Loreen ; Zhang, Qiang ; Gillespie, Paul ; Haynes, Nancy-Ellen ; Thakkar, Kshitij Chhabilbhai</creator><creatorcontrib>Anderson, Kevin William ; Fotouhi, Nader ; Pietranico-Cole, Sherrie Lynn ; Qi, Lida ; Goodnow Jr, Robert Alan ; Scott, Nathan Robert ; Guertin, Kevin Richard ; Tilley, Jefferson Wright ; Myers, Michael Paul ; Rossman, Pamela Loreen ; Zhang, Qiang ; Gillespie, Paul ; Haynes, Nancy-Ellen ; Thakkar, Kshitij Chhabilbhai</creatorcontrib><description>Det er her tilveiebrakt forbindelser med formel (I): så vel som farmasøytisk akseptable salter derav, hvor substituentene er som beskrevet i beskrivelsen. Disse forbindelsene og de farmasøytiske preparatene som inneholder dem, er anvendelige for behandling av sykdommer som for eksempel diabetes mellitus type II og metabolsk syndrom.
Provided herein are compounds of the formula (I):
as well as pharmaceutically acceptable salts thereof, wherein the substituents are as those disclosed in the specification. These compounds, and the pharmaceutical compositions containing them, are useful for the treatment of diseases such as, for example, type II diabetes mellitus and metabolic syndrome.</description><language>nor</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2018</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20180115&DB=EPODOC&CC=NO&NR=341746B1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76290</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20180115&DB=EPODOC&CC=NO&NR=341746B1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>Anderson, Kevin William</creatorcontrib><creatorcontrib>Fotouhi, Nader</creatorcontrib><creatorcontrib>Pietranico-Cole, Sherrie Lynn</creatorcontrib><creatorcontrib>Qi, Lida</creatorcontrib><creatorcontrib>Goodnow Jr, Robert Alan</creatorcontrib><creatorcontrib>Scott, Nathan Robert</creatorcontrib><creatorcontrib>Guertin, Kevin Richard</creatorcontrib><creatorcontrib>Tilley, Jefferson Wright</creatorcontrib><creatorcontrib>Myers, Michael Paul</creatorcontrib><creatorcontrib>Rossman, Pamela Loreen</creatorcontrib><creatorcontrib>Zhang, Qiang</creatorcontrib><creatorcontrib>Gillespie, Paul</creatorcontrib><creatorcontrib>Haynes, Nancy-Ellen</creatorcontrib><creatorcontrib>Thakkar, Kshitij Chhabilbhai</creatorcontrib><title>Pyrazoler, farmasøytisk preparat inneholdende samme, slike forbindelser som terapeutisk aktive substanser samt slike forbindelser for anvendelse i behandling av sykdommer</title><description>Det er her tilveiebrakt forbindelser med formel (I): så vel som farmasøytisk akseptable salter derav, hvor substituentene er som beskrevet i beskrivelsen. Disse forbindelsene og de farmasøytiske preparatene som inneholder dem, er anvendelige for behandling av sykdommer som for eksempel diabetes mellitus type II og metabolsk syndrom.
Provided herein are compounds of the formula (I):
as well as pharmaceutically acceptable salts thereof, wherein the substituents are as those disclosed in the specification. These compounds, and the pharmaceutical compositions containing them, are useful for the treatment of diseases such as, for example, type II diabetes mellitus and metabolic syndrome.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2018</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNjT0KwkAQhdNYiHqHOUAsgqK9oliphb1MzMQs-8vMJhCv5AXsvZiLWlpYPd7j-3jD7H7sGW_eEOdQI1uU56OPSjQEpoCMEZRz1HhTkasIBK2lHMQoTVB7LlVajRCDeAuRGAO1bx91VF0S2lIiujeBNv4yUwF0HX06KCipQVcZ5a6AHUivK59eeZwNakzE5JujDLab03o3peDPJAEv5Cie94fZvFjOF6tVMfsDeQGfVFuu</recordid><startdate>20180115</startdate><enddate>20180115</enddate><creator>Anderson, Kevin William</creator><creator>Fotouhi, Nader</creator><creator>Pietranico-Cole, Sherrie Lynn</creator><creator>Qi, Lida</creator><creator>Goodnow Jr, Robert Alan</creator><creator>Scott, Nathan Robert</creator><creator>Guertin, Kevin Richard</creator><creator>Tilley, Jefferson Wright</creator><creator>Myers, Michael Paul</creator><creator>Rossman, Pamela Loreen</creator><creator>Zhang, Qiang</creator><creator>Gillespie, Paul</creator><creator>Haynes, Nancy-Ellen</creator><creator>Thakkar, Kshitij Chhabilbhai</creator><scope>EVB</scope></search><sort><creationdate>20180115</creationdate><title>Pyrazoler, farmasøytisk preparat inneholdende samme, slike forbindelser som terapeutisk aktive substanser samt slike forbindelser for anvendelse i behandling av sykdommer</title><author>Anderson, Kevin William ; Fotouhi, Nader ; Pietranico-Cole, Sherrie Lynn ; Qi, Lida ; Goodnow Jr, Robert Alan ; Scott, Nathan Robert ; Guertin, Kevin Richard ; Tilley, Jefferson Wright ; Myers, Michael Paul ; Rossman, Pamela Loreen ; Zhang, Qiang ; Gillespie, Paul ; Haynes, Nancy-Ellen ; Thakkar, Kshitij Chhabilbhai</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_NO341746BB13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>nor</language><creationdate>2018</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>Anderson, Kevin William</creatorcontrib><creatorcontrib>Fotouhi, Nader</creatorcontrib><creatorcontrib>Pietranico-Cole, Sherrie Lynn</creatorcontrib><creatorcontrib>Qi, Lida</creatorcontrib><creatorcontrib>Goodnow Jr, Robert Alan</creatorcontrib><creatorcontrib>Scott, Nathan Robert</creatorcontrib><creatorcontrib>Guertin, Kevin Richard</creatorcontrib><creatorcontrib>Tilley, Jefferson Wright</creatorcontrib><creatorcontrib>Myers, Michael Paul</creatorcontrib><creatorcontrib>Rossman, Pamela Loreen</creatorcontrib><creatorcontrib>Zhang, Qiang</creatorcontrib><creatorcontrib>Gillespie, Paul</creatorcontrib><creatorcontrib>Haynes, Nancy-Ellen</creatorcontrib><creatorcontrib>Thakkar, Kshitij Chhabilbhai</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Anderson, Kevin William</au><au>Fotouhi, Nader</au><au>Pietranico-Cole, Sherrie Lynn</au><au>Qi, Lida</au><au>Goodnow Jr, Robert Alan</au><au>Scott, Nathan Robert</au><au>Guertin, Kevin Richard</au><au>Tilley, Jefferson Wright</au><au>Myers, Michael Paul</au><au>Rossman, Pamela Loreen</au><au>Zhang, Qiang</au><au>Gillespie, Paul</au><au>Haynes, Nancy-Ellen</au><au>Thakkar, Kshitij Chhabilbhai</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Pyrazoler, farmasøytisk preparat inneholdende samme, slike forbindelser som terapeutisk aktive substanser samt slike forbindelser for anvendelse i behandling av sykdommer</title><date>2018-01-15</date><risdate>2018</risdate><abstract>Det er her tilveiebrakt forbindelser med formel (I): så vel som farmasøytisk akseptable salter derav, hvor substituentene er som beskrevet i beskrivelsen. Disse forbindelsene og de farmasøytiske preparatene som inneholder dem, er anvendelige for behandling av sykdommer som for eksempel diabetes mellitus type II og metabolsk syndrom.
Provided herein are compounds of the formula (I):
as well as pharmaceutically acceptable salts thereof, wherein the substituents are as those disclosed in the specification. These compounds, and the pharmaceutical compositions containing them, are useful for the treatment of diseases such as, for example, type II diabetes mellitus and metabolic syndrome.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | nor |
| recordid | cdi_epo_espacenet_NO341746BB1 |
| source | esp@cenet |
| subjects | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| title | Pyrazoler, farmasøytisk preparat inneholdende samme, slike forbindelser som terapeutisk aktive substanser samt slike forbindelser for anvendelse i behandling av sykdommer |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-30T11%3A56%3A54IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=Anderson,%20Kevin%20William&rft.date=2018-01-15&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ENO341746BB1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |